Odisha News In English

Prameya English, Prameyanews.com, Odisha Latest News, Odisha News Online

Over 9L beneficiaries of age group 18-44 vaccinated under phase-3 of vaccination Drive

6/05/2021 at 2:45 PM

New Delhi, May 6: There has been an unprecedented surge in the number of COVID19 cases in the country since the past few weeks. The health infrastructure of several States and UTs has been overwhelmed by the very high number of daily cases and increased mortality.

Following the spirit of Vasudhaiva Kutumbakam, the global community has extended a helping hand in supporting efforts of Government of India in this collective fight against the global COVID19 pandemic.

Government of India has been receiving international donations/aid of Covid-19 relief medical supplies and equipment since 27 April 2021 from different countries. All items received so far are allocated to the states/institutions and substantial part of it stands delivered. This is an ongoing exercise. The aim is to extend all support and assistance through various means and measures to strengthen the States’ and UT’s efforts during this critical phase.

On the other hand, the cumulative number of COVID19 vaccine doses administered in the country has crossed 16.25 Cr today as the Phase-3 of the nationwide Vaccination Drive expands further.

9,04,263 beneficiaries of the age group 18-44 years received their first dose of COVID vaccine across 12 States. These states are Chhattisgarh (1,026), Delhi (1,29,096), Gujarat (1,96,860), Jammu and Kashmir (16,387), Haryana (1,23,484), Karnataka (5,328), Maharashtra (1,53,966), Odisha (21,031), Punjab (1,535), Rajasthan (1,80,242), Tamil Nadu (6,415) and UP (68,893).

Cumulatively, 16,25,13,339 vaccine doses have been administered through 29,34,844 sessions, as per the provisional report till 7 am today. These include 94,80,739 HCWs who have taken the 1st dose and 63,54,113 HCWs who have taken the 2nd dose, 1,36,57,922 FLWs (1stdose), 74,25,592 FLWs (2nddose), 9,04,263 beneficiaries under 18-45 age group (1st dose), 5,31,16,901 1st dose beneficiaries and 1,29,15,354 2nd dose beneficiaries more than 60 years old and 5,38,15,026 (1st dose) and 48,43,429 (2nd dose) beneficiaries aged 45 to 60 years.

   Related Posts


Loading...